KRM22 PLC Change of Registered Office

RNS Number : 5772C

KRM22 PLC

03 September 2024

 

KRM22 plc

("KRM22", the "Group" or the "Company")

Change of Registered Office

 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, announces that its registered office has changed to 8^th Floor, Capital House, 84 - 86 King William Street, London, EC4N 7BL.

 

 

For further information please contact:

 

KRM22 plc                                                                                          Garry Jones, Chairman Dan Carter, CEO Kim Suter, CFO	[e-mail]
Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)                        Carl Holmes / Rory Sale (Corporate Finance) Sunila de Silva (ECM)	[phone]

 

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018.  The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management.  The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CROBXGDCDUGDGSD